Browsed by
Tag: Therapy

Therapy by AI holds promise and challenges : Shots
Therapy by AI holds promise and challenges : Shots

Therapy by AI holds promise and challenges : Shots

Just a year ago, Chukurah Ali had fulfilled a dream of owning her own bakery — Coco’s Desserts in St. Louis, Mo. — which specialized in the sort of custom-made ornate wedding cakes often featured in baking show competitions. Ali, a single mom, supported her daughter and mother by baking recipes she learned from her beloved grandmother. But last February, all that fell apart, after a car accident left Ali hobbled by injury, from head to knee. “I could barely…

Read More Read More

Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study
Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study

Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study

We observed a diminished systemic HT prevalence and an elevated mortality danger for systemic HT end users in the two study populations in the wake of the 2002 WHI publication with the most pronounced inclination offered in the singleton populace. The conclusions suggest an alteration in the HT user profile just after 2002 with a unique pattern of HT use, most likely owing to the healthiest users determining to either fall systemic HT or switching to local HT, as tips…

Read More Read More

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the U.S. Food stuff and Drug Administration (Food and drug administration) has accepted an Investigational New Drug (IND) software for the firm’s HT-001 therapeutic for the treatment for rash and pores and skin issues associated with epidermal growth factor receptor (EGFR) inhibitor treatment. EGFR inhibitors are critical therapeutic agents for the remedy…

Read More Read More

Could white light therapy improve fatigue?
Could white light therapy improve fatigue?

Could white light therapy improve fatigue?

Share on PinterestA modest new study indicates light-weight treatment may make improvements to fatigue in many sclerosis. Impression credit history: Cavan Images/Getty Illustrations or photos. A new research from Austria supports the idea that light therapy may support persons with many sclerosis (MS) minimize the overwhelming tiredness that frequently accompanies the sickness. While the authors of the analyze sought to verify the result of dazzling gentle treatment, they uncovered that even dim pink gentle made a similarly clinically substantial advancement….

Read More Read More

Radical new therapy for Parkinson’s will use stem cell transplants | Parkinson’s disease
Radical new therapy for Parkinson’s will use stem cell transplants | Parkinson’s disease

Radical new therapy for Parkinson’s will use stem cell transplants | Parkinson’s disease

Early next year, a radical new therapy for Parkinson’s sickness involving tissue transplants will acquire its very first trial with clients – together with a team from the British isles. Stem cells developed in the laboratory and remodeled into nerve cells will be made use of to replace all those wrecked by the disorder. It is hoped that these will end the spread of debilitating indications. “It has taken a lengthy time to get to this stage but hopefully effects…

Read More Read More

FDA approves most expensive drug ever, a .5 million-per-dose gene therapy for hemophilia B
FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B

FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B

Washington — U.S. wellness regulators on Tuesday approved the initially gene treatment for hemophilia, a $3.5 million just one-time therapy for the blood-clotting condition. The Food items and Drug Administration cleared Hemgenix, an IV treatment method for older people with hemophilia B, the much less common sort of the genetic condition which primarily impacts adult men. Currently, individuals obtain repeated, high priced IVs of a protein that assists blood clot and protect against bleeding. Signage for CSL Behring, a device of…

Read More Read More